Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | QSQ883V35U |
InChI Key | TVTXCJFHQKSQQM-LJQIRTBHSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C31H29Cl2F2N3O4 |
Molecular Weight | 616.49 |
AlogP | 6.94 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 7.0 |
Polar Surface Area | 111.45 |
Molecular species | ACID |
Aromatic Rings | 3.0 |
Heavy Atoms | 42.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | PubMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Other nuclear protein
|
- | 6-6 | 0 | - | - | |
Transcription factor
|
- | 9-10 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Leukemia, Myeloid, Acute | 3 | D015470 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Polycythemia Vera | 2 | D011087 | ClinicalTrials |
Glioblastoma | 1 | D005909 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
Lymphoma, Non-Hodgkin | 1 | D008228 | ClinicalTrials |
Thrombocythemia, Essential | 1 | D013920 | ClinicalTrials |
Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1229705-06-9 |
ChEMBL | CHEMBL2402737 |
DrugBank | DB12325 |
FDA SRS | QSQ883V35U |
PubChem | 53358942 |
SureChEMBL | SCHEMBL442856 |
ZINC | ZINC000096273105 |